Comparison of Epidermal Growth Factor and Heparin‐binding Epidermal Growth Factor–like Growth Factor for Prevention of Experimental Necrotizing Enterocolitis
Authors:
- 1 July 2008
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (1) , 11-18
Abstract
Background: Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease of prematurely born infants. Epidermal growth factor (EGF) and heparin‐binding EGF‐like growth factor (HB‐EGF) have protective effects against intestinal injury. The aim of this study was to compare the effect of oral administration of HB‐EGF, EGF, or both on the incidence of NEC in a neonatal rat model.Materials and Methods: Premature rats were fed by hand and exposed to asphyxia and cold stress to develop NEC. Four diets were used: formula (NEC), formula supplemented with 500 ng/mL HB‐EGF (HB), 500 ng/mL EGF (EGF), or a combination of both (E+HB). Ileal injury, endogenous HB‐EGF production, expression of EGF receptors, goblet cell density, and expression of apoptotic proteins were evaluated.Results: Oral administration of either EGF or HB‐EGF significantly reduced the incidence of NEC; however, EGF provided better protection in physiologically relevant doses. Simultaneous administration of both growth factors did not result in any synergistic protective effect against NEC. There were no significant differences between treatment groups in ileal gene expression of EGF receptors or HB‐EGF. However, the balance of apoptotic proteins in the ileum was shifted in favor of cell survival in EGF‐treated rats. This mechanism may be responsible for the higher efficiency of EGF protection against NEC.Conclusions: These data suggest that a physiological dosage of EGF or a pharmacological dosage of HB‐EGF could be used for prevention of NEC.Keywords
Funding Information
- National Institute of Child Health and Human Development (HD39657)
This publication has 40 references indexed in Scilit:
- Epidermal Growth Factor Reduces Hepatic Sequelae in Experimental Necrotizing EnterocolitisNeonatology, 2006
- Bile Acids Induce Ileal Damage During Experimental Necrotizing EnterocolitisGastroenterology, 2006
- Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Increased Epidermal Growth Factor Levels in Human Milk of Mothers with Extremely Premature InfantsPediatric Research, 2003
- Ileal Cytokine Dysregulation in Experimental Necrotizing Enterocolitis Is Reduced by Epidermal Growth FactorJournal of Pediatric Gastroenterology and Nutrition, 2003
- Neonatal Necrotizing Enterocolitis: Clinical Considerations and Pathogenetic ConceptsPediatric and Developmental Pathology, 2003
- Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat modelAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- EGF Regulates Early Embryonic Mouse Gut Development in Chemically Defined Organ CulturePediatric Research, 2000
- Diminished epidermal growth factor levels in infants with necrotizing enterocolitisJournal of Pediatric Surgery, 2000
- Necrotizing Enterocolitis: A Review of Pathogenetic Mechanisms and Implications for PreventionPediatric Pathology, 1993